Disease Info Card

Lymphangiectasis, Intestinal

Information about Lymphangiectasis, Intestinal: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lymphangiectasis, Intestinal

Most recent studies have shown that Lymphangiectasis, Intestinal shares some biological mechanisms with celiac-disease, chronic-diarrhea, crohn-disease, diarrhea, dog-diseases, edema, gastrointestinal-diseases, hemorrhage, hypogammaglobulinemia, hypoproteinemia, immunologic-deficiency-syndromes, intestinal-diseases, lymphangiectasis, lymphedema, lymphopenia, malabsorption-syndrome, pathological-dilatation, primary-intestinal-lymphangiectasia, primary-intestinal-lymphangiectasis, protein-losing-enteropathies.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphangiectasis, Intestinal, and have been seen in publications frequently: Cell Proliferation, Chemotaxis, Coagulation, Endocytosis, Excretion, Fibrinolysis, Glycosylation, Hypersensitivity, Immune Response, Intestinal Absorption, Killer Activity, Lactation, Localization, Lymphangiogenesis, Neutrophil Chemotaxis, Pathogenesis, Phagocytosis, Pinocytosis, Transport, Transposition

Quite a number of genes have been found to play important roles in Lymphangiectasis, Intestinal, such as ALB, CD4, CP, FLT4, GLB1, GNAI1, IL6, KIT, LCT, MCAT, MCPH1, PTH, SERPINA1, SLC16A1, SST, TF, USB1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.